Geode Capital Management
TCRT icon

Geode Capital Management’s Alaunos Therapeutics TCRT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$77.4K Buy
15,946
+336
+2% +$1.63K ﹤0.01% 4128
2025
Q1
$22.6K Buy
15,610
+394
+3% +$571 ﹤0.01% 4327
2024
Q4
$28.9K Sell
15,216
-1,117
-7% -$2.12K ﹤0.01% 4333
2024
Q3
$53.7K Sell
16,333
-147,255
-90% -$485K ﹤0.01% 4250
2024
Q2
$114K Buy
163,588
+13,171
+9% +$9.21K ﹤0.01% 4097
2024
Q1
$272K Sell
150,417
-2,105,934
-93% -$3.81M ﹤0.01% 3833
2023
Q4
$160K Buy
2,256,351
+92,878
+4% +$6.57K ﹤0.01% 4015
2023
Q3
$285K Sell
2,163,473
-90,953
-4% -$12K ﹤0.01% 3828
2023
Q2
$1.15M Buy
2,254,426
+117,786
+6% +$60.1K ﹤0.01% 3291
2023
Q1
$1.35M Buy
2,136,640
+42,302
+2% +$26.7K ﹤0.01% 3218
2022
Q4
$1.36M Buy
2,094,338
+17,840
+0.9% +$11.6K ﹤0.01% 3216
2022
Q3
$3.57M Buy
2,076,498
+1,681
+0.1% +$2.89K ﹤0.01% 2855
2022
Q2
$2.57M Sell
2,074,817
-1,451,623
-41% -$1.8M ﹤0.01% 3026
2022
Q1
$2.3M Sell
3,526,440
-53,987
-2% -$35.2K ﹤0.01% 3192
2021
Q4
$3.9M Buy
3,580,427
+240,885
+7% +$263K ﹤0.01% 3028
2021
Q3
$6.08M Sell
3,339,542
-212,167
-6% -$386K ﹤0.01% 2797
2021
Q2
$9.38M Buy
3,551,709
+16,648
+0.5% +$43.9K ﹤0.01% 2502
2021
Q1
$12.7M Buy
3,535,061
+446,956
+14% +$1.61M ﹤0.01% 2194
2020
Q4
$7.78M Buy
3,088,105
+128,870
+4% +$325K ﹤0.01% 2332
2020
Q3
$7.46M Buy
2,959,235
+42,377
+1% +$107K ﹤0.01% 2148
2020
Q2
$9.57M Buy
2,916,858
+251,002
+9% +$823K ﹤0.01% 1946
2020
Q1
$6.53M Buy
2,665,856
+438,897
+20% +$1.08M ﹤0.01% 1993
2019
Q4
$10.5M Buy
2,226,959
+140,447
+7% +$663K ﹤0.01% 1978
2019
Q3
$8.93M Buy
2,086,512
+81,329
+4% +$348K ﹤0.01% 2017
2019
Q2
$11.7M Buy
2,005,183
+248,327
+14% +$1.45M ﹤0.01% 1837
2019
Q1
$6.76M Buy
1,756,856
+204,840
+13% +$789K ﹤0.01% 2149
2018
Q4
$2.9M Buy
1,552,016
+145,129
+10% +$271K ﹤0.01% 2552
2018
Q3
$4.5M Buy
1,406,887
+54,938
+4% +$176K ﹤0.01% 2416
2018
Q2
$4.08M Buy
1,351,949
+164,983
+14% +$498K ﹤0.01% 2439
2018
Q1
$4.65M Buy
1,186,966
+26,313
+2% +$103K ﹤0.01% 2283
2017
Q4
$4.81M Buy
1,160,653
+22,575
+2% +$93.5K ﹤0.01% 2236
2017
Q3
$6.99M Buy
1,138,078
+25,950
+2% +$159K ﹤0.01% 1993
2017
Q2
$6.92M Buy
1,112,128
+95,701
+9% +$595K ﹤0.01% 1916
2017
Q1
$6.44M Buy
1,016,427
+38,173
+4% +$242K ﹤0.01% 1929
2016
Q4
$5.23M Buy
978,254
+28,294
+3% +$151K ﹤0.01% 2035
2016
Q3
$5.35M Buy
949,960
+51,702
+6% +$291K ﹤0.01% 1931
2016
Q2
$4.93M Buy
898,258
+15,791
+2% +$86.7K ﹤0.01% 1923
2016
Q1
$6.55K Sell
882,467
-28,677
-3% -$213 ﹤0.01% 1683
2015
Q4
$7.57M Buy
911,144
+85,432
+10% +$710K ﹤0.01% 1572
2015
Q3
$7.44M Buy
825,712
+28,843
+4% +$260K ﹤0.01% 1559
2015
Q2
$9.56M Buy
796,869
+126,157
+19% +$1.51M 0.01% 1445
2015
Q1
$7.22M Buy
670,712
+93,497
+16% +$1.01M ﹤0.01% 1618
2014
Q4
$2.93M Buy
577,215
+37,766
+7% +$191K ﹤0.01% 2172
2014
Q3
$1.42M Buy
539,449
+4,410
+0.8% +$11.6K ﹤0.01% 2577
2014
Q2
$2.16M Buy
535,039
+2,243
+0.4% +$9.04K ﹤0.01% 2330
2014
Q1
$2.44M Buy
532,796
+73,062
+16% +$335K ﹤0.01% 2218
2013
Q4
$2M Buy
459,734
+104,893
+30% +$455K ﹤0.01% 2293
2013
Q3
$1.4M Buy
354,841
+23,143
+7% +$91.4K ﹤0.01% 2390
2013
Q2
$697K Buy
+331,698
New +$697K ﹤0.01% 2680